Business context and reporting period
Entity clarification: The supplied filing is Rosecliff Acquisition Corp I’s Form 10-Q for the quarter ended September 30, 2022, not a filing by Spectral AI, Inc. It describes a blank-check company seeking a business combination; it had not begun operations and reported no operating revenue.
Key financial metrics
| Metric | Three months ended September 30, 2022 | Nine months ended September 30, 2022 |
|---|---|---|
| Operating revenue | None | None |
| General and administrative expenses | $237,071 | $950,917 |
| Net income | $1,185,674 | $9,698,494 |
| Net income per share, Class A and Class B | $0.04 | $0.31 |
| Trust account interest income | $1,122,395 | $1,546,924 |
| Gain from change in warrant fair value | $525,600 | $9,354,242 |
Profit was driven by non-operating trust interest and warrant-liability fair-value gains, rather than operating activity. Operating margins are not meaningful because the company had no revenue.
At September 30, 2022, cash outside the trust was $517,838; the trust held $254,228,158. The company reported a $2,429,532 working-capital deficit, total liabilities of $12,987,174, including $8,855,000 of deferred underwriting fees payable upon a completed business combination, and stockholders’ deficit of $12,072,932. It reported no long-term debt. Nine-month operating cash use was $597,600; investing cash inflow was $346,006, reflecting trust withdrawals for taxes. No cash was provided by financing activities in the period.
Material changes versus the prior comparable period
Third-quarter net income declined to $1,185,674 from $2,227,170 in 2021, principally because the warrant-liability fair-value gain was lower ($525,600 versus $3,416,400); trust interest increased to $1,122,395 from $3,506. For the first nine months, net income rose to $9,698,494 from $2,546,138, primarily reflecting a larger warrant fair-value gain ($9,354,242 versus $4,599,000) and increased trust interest ($1,546,924 versus $23,010). These gains are non-cash and may fluctuate.
Cash outside the trust declined from $769,432 at December 31, 2021 to $517,838 at September 30, 2022. Warrant liabilities fell from $10,142,642 to $788,400. The trust balance increased from $253,027,240 to $254,228,158.
Outlook, risks, and unusual items
- The company’s then-current deadline to complete a business combination was February 17, 2023. Management said completion by that date was uncertain and disclosed substantial doubt about the company’s ability to continue as a going concern; sponsor and other related-party funding was possible but not committed.
- In March 2022, Rosecliff and GT Gettaxi Limited mutually terminated their business combination agreement after reviewing projections and failing to agree on a valuation adjustment. Rosecliff said it would continue seeking a target.
- A November 9, 2022 preliminary proxy proposed extending the deadline to February 17, 2024, removing the $5,000,001 net-tangible-asset redemption limitation, and allowing adjournment of the special meeting. These were proposals, not reported as approved in this filing.
- The Inflation Reduction Act’s 1% excise tax on certain stock repurchases beginning in 2023 could affect redemptions, available transaction cash, or liquidation distributions; applicability was uncertain.
- If no business combination was completed by the applicable deadline, public shares would be redeemed and the company would liquidate; warrants could expire worthless. COVID-19, geopolitical events, market volatility, and the ability to secure financing were also cited as risks.
- Management reported disclosure controls were effective and no material change in internal control over financial reporting during the quarter. No legal proceedings were reported.
Important facts for investors to verify
- Confirm the filing issuer: this is Rosecliff Acquisition Corp I, not Spectral AI, Inc.
- Check the outcome of the proposed deadline extension and redemption-limit amendments, and the company’s ultimate business-combination or liquidation status.
- Assess liquidity outside the trust, the working-capital deficit, and whether any sponsor or third-party financing was obtained.
- Distinguish recurring cash resources from reported earnings, which were substantially affected by warrant remeasurement and trust interest.
- Review redemption and excise-tax effects, deferred underwriting fees, and the risk that warrants could become worthless.